Technetium TC-99M Pyrophosphate Kit Injection Shortage: Supply Updates and Manufacturer Status

Drug Shortages high FDA · · United States

The FDA reports a current shortage of Technetium TC-99M Pyrophosphate Kit Injection, a medical imaging agent, with manufacturers expecting supply recovery in 2026.

What’s in Shortage

Technetium TC-99M Pyrophosphate Kit Injection is currently listed as in shortage. This medication is used within the therapeutic category of Medical Imaging. It is available under the brand names TECHNESCAN PYP and KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE. The current status of this medication is listed as “Current” on the FDA shortage database.

Which Manufacturers Are Affected

Currently, all listed manufacturers report that the product is unavailable, with supply recovery not expected until 2026.

  • Curium US LLC

    • Status: Unavailable
    • Note: Supply anticipated in Q1 2026
    • Presentation: Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)
    • Contact: 888-744-1414
  • Sun Pharmaceutical Industries, Inc.

    • Status: Unavailable
    • Note: New supply anticipated in Q2 2026
    • Presentation: CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1 and 45567-0060-2)
    • Contact: 800-818-4555

Why There’s a Shortage

The reason provided for this shortage is a shortage of an active ingredient necessary for the production of the injection.

What Patients Should Do

If you are scheduled for medical imaging that requires Technetium TC-99M Pyrophosphate, please take the following steps:

  • Consult Your Healthcare Provider: Discuss the shortage with your doctor or the medical imaging department to understand how this affects your procedure.
  • Contact the Manufacturer: You may use the contact information provided above to inquire about the most recent supply updates directly from the manufacturers.
  • Speak with a Pharmacist: Your pharmacist may have information regarding institutional availability or local supply status.

Disclaimer: Patients should always consult their healthcare provider regarding medical decisions. Do not make changes to your medical care without professional consultation.

Source

Attribution: FDA Drug Shortage Database

  • Initial Posting Date: 12/27/2023
  • Last Updated: 02/04/2026